back to top
 

Press Release

Pharmacoscintigraphic and Pharmacokinetic Analysis of CTx 1301, a Novel Trimodal Oral Formulation for Release of Dexmethylphenidate in Healthy Adults

Presented at 2018 American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting.

DOWNLOAD POSTER